Tuesday, August 16, 2022
wellness India Expo
Home Tags Cadila

Tag: Cadila

Jawed Zia appointed as CEO of Cadila Pharma

Zia will lead the strategy and business operations of Cadila’s branded prescriptions pharma business

Cadila Healthcare is now Zydus Lifesciences

Zydus unveils its ‘innovation and care’ centric corporate brand identity

Cadila Pharma expands its oncology portfolio with monoclonal antibody, Tarzed

TARZED is considered safe and more efficacious compared to conventional treatment medicines for breast cancer

Healthcare leaders at BRICS event call for partnership in infrastructure development

Partnership in infrastructure development at quick turnaround times is vital for India’s healthcare system..........................

Zydus Cadila vaccine candidate gets nod for Phase III clinical trials

The candidate has been supported by the National Biopharma Mission (NBM) under the aegis of BIRAC and the Department of Biotechnology, Government of India.......................

Zydus to begin Phase I trials of its inflammation drug, ZYIL1

Phase I trial will study the safety, tolerability, pharmacokinetics and pharmacodynamics of ZYIL1 in healthy human volunteers. Zydus has secured a Strong IP portfolio with multiple patents filed in all major countries.....................

Cadila Pharma launches Tikacad to address cardiac health issues

Tikacad® containing Ticagrelor reduces the rate of stent thrombosis in patients who have been stented for treatment of ACS. Ticagrelor can also be used for the primary prevention of stroke in patients with coronary artery disease as approved by the USFDA...............

Cadila launches Adalimumab biosimilar, Cadalimab in India

In an effort to strengthen their the biosimilar product portfolio, Cadalimab™ is the fourth biosimilar launched in the last 2 months by Cadila Pharmaceuticals..................

Cadila Pharma launches biosimilar drug, Ritucad to treat blood cancer &...

Biosimilar Rituximab is used for the treatment of blood cancer and rheumatoid arthritis and will be launched under the brand name Ritucad™......................

Pharma industry continues its growth march says global report

Besides host of factors, the new treatments involving bio-organisms, several new vaccines ...